Viewing nowCombinationRobelito Tablet 150/20 mg (Irbesartan, Atorvastatin)
Atorvastatin Calcium Trihydrate 21.7mg · Irbesartan 150mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 201309480 · Approved 2013.09.27 · Insurance code 643506670
Treatment of hyperlipidemia and hypertension (including diabetic nephropathy); prevention of cardiovascular disease
This medication is intended for patients who need to take irbesartan and atorvastatin simultaneously. Irbesartan is used to treat essential hypertension and nephropathy in patients with hypertension and type 2 diabetes. Atorvastatin is effective for reducing cardiovascular disease risk and treating hyperlipidemia. It particularly helps to reduce the risk of myocardial infarction, stroke, need for vascular interventions, angina, and heart failure hospitalization. Additionally, it is used to improve cholesterol levels in patients with hypercholesterolemia and various dyslipidemias. This medication simultaneously improves cardiovascular health and blood pressure control through the combined action of both components.
This drug is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, irbesartan and atorvastatin. ○ Irbesartan This drug may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan 150 mg orally once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in special cases (such as at the start of treatment, in patients on hemodialysis, or in elderly patients 75 years of age or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be given concomitantly. The effect is increased particularly when given concomitantly with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be given concomitantly to achieve the target blood pressure. - Elderly patients Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients 75 years of age or older. - Patients with renal impairment Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients on hemodialysis. - Patients with hepatic impairment Dose adjustment is generally not necessary in patients with mild to moderate hepatic impairment, but it is recommended not to exceed 150 mg per day. There is no clinical experience in patients with severe hepatic impairment. ○ Atorvastatin calcium Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This drug may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. - Patients with renal impairment : Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. - Elderly patients : The efficacy and safety in patients 70 years of age or older are similar to those in the general adult patient population.
This medication should not be taken during pregnancy. If pregnancy is confirmed, it must be stopped immediately as it can cause serious harm to the fetus. Since this medication may cause muscle issues, notify your doctor immediately if you experience muscle pain, weakness, or extreme fatigue. Treatment should be stopped if muscle enzyme levels rise significantly. Patients with liver dysfunction or a history of liver disease should undergo regular liver function tests while taking this medication, and consult their doctor if they experience liver dysfunction symptoms. Be cautious as blood pressure may drop too low or symptoms such as dizziness or fainting may occur when starting the medication or changing the dosage. This medication may increase potassium levels, so patients at risk of hyperkalemia should have their blood potassium levels checked regularly. Interactions may occur when taken with other antihypertensives or certain diuretics, potassium supplements, so consult with a doctor or pharmacist. It is not recommended for children or adolescents under 18 as safety has not been established. For the elderly, as bodily responses may vary, treatment should start at a lower dose, observing their condition thereafter. While taking this medication, gastrointestinal disturbances such as dyspepsia, headache, dizziness, muscle pain, fatigue, and edema may occur. If symptoms are severe or persistent, inform healthcare professionals. Also, this medication may interact with certain drugs, so if you are currently taking any medications, be sure to inform your healthcare provider.
Not everyone experiences these, and they can vary from person to person.
Keep this medication in a tightly closed container to prevent it from being exposed to air or moisture. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature.
Yellow oval film-coated tablet
30 tablets/bottle, 30 tablets/box [10 tablets/PTPX3], 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAtorvastatin Calcium Trihydrate 21.7mg · Irbesartan 150mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium Trihydrate 10.85mg · Irbesartan 150mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium Trihydrate 10.85mg · Irbesartan 300mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium Trihydrate 21.7mg · Irbesartan 300mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.